Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients ; volume:6 ; number:4 ; day:20 ; month:7 ; year:2005 ; pages:319-321 ; date:9.2005
The journal of headache and pain ; 6, Heft 4 (20.7.2005), 319-321, 9.2005
- Creator
-
Sternieri, E.
- Contributor
-
Pinetti, D.
Coccia, C. P. R.
Leone, S.
Bertolini, A.
Ferrari, A.
SpringerLink (Online service)
- DOI
-
10.1007/s10194-005-0220-z
- URN
-
urn:nbn:de:1111-2016040818398
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sternieri, E.
- Pinetti, D.
- Coccia, C. P. R.
- Leone, S.
- Bertolini, A.
- Ferrari, A.
- SpringerLink (Online service)
Other Objects (12)
Positiones Respondent
Standardizing adverse drug event reporting data
Respondent-Driven Sampling
Respondent driven sampling
Respondent driven sampling
Respondent-Driven Sampling
Respondent driven sampling
Respondent driven sampling
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Seasonal and Geographic Variation in Adverse Event Reporting
Sex differences in pharmacokinetics predict adverse drug reactions in women
Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database
Positiones Respondent
Standardizing adverse drug event reporting data
Respondent-Driven Sampling
Respondent driven sampling
Respondent driven sampling
Respondent-Driven Sampling
Respondent driven sampling
Respondent driven sampling
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Seasonal and Geographic Variation in Adverse Event Reporting
Sex differences in pharmacokinetics predict adverse drug reactions in women
Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database
Positiones Respondent
Standardizing adverse drug event reporting data
Respondent-Driven Sampling
Respondent driven sampling
Respondent driven sampling
Respondent-Driven Sampling
Respondent driven sampling
Respondent driven sampling
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Seasonal and Geographic Variation in Adverse Event Reporting
Sex differences in pharmacokinetics predict adverse drug reactions in women